KNTPF 財務： Kintor Pharmaceutical Limited AI 分析

Q: 技術分析指標如何適用於 KNTPF？

根據技術分析，Kintor Pharmaceutical Limited 的綜合信號為 Sell。Kintor Pharmaceutical Limited 有 1 個買入信號，4 個中性信號和 2 個賣出信號。

Q: KNTPF 的費波那契回檔水準是多少？

Kintor Pharmaceutical Limited 的費波那契回檔水準是 介於 78.6% 和 100% 之間。

Q: Kintor Pharmaceutical Limited 的 RSI 是多少？

Kintor Pharmaceutical Limited 的 RSI 目前為 68.57，表明處於 中立 狀態

Q: Kintor Pharmaceutical Limited 接下來 12 個月的價格是多少？

Kintor Pharmaceutical Limited KNTPF 接下來 12 個月的價格預估為 $1.28。

Q: Kintor Pharmaceutical Limited 預計會漲到多高？

據華爾街分析師稱，Kintor Pharmaceutical Limited 預計將達到 $1.55 的高預測值。

首頁

股票

KNTPF

預測

KNTPF 股票價格預測

Kintor Pharmaceutical Limited

$0.34

收盤價：Jan 23, 16:00:00 GMT-5

$0.34

盤後：Jan 23, 16:35:57 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$0.3492

開盤價

$0.2588

當日範圍

$0.2588 - $0.3492

52週區間

$0.1441 - $0.3643

交易量

460

平均成交量

每股盈餘 (TTM)

-0.05

股息收益率

市值

$163.7M

什麼是 KINTOR PHARMACEUTICAL LTD.？

Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 136 full-time employees. The company went IPO on 2020-05-22. The firm's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The firm has two core drugs in the dermatology field, KX-826 and GT20029. The firm's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for KNTPF in the upcoming periods. Looking toward the future, our 2024 projection indicates an average price target of $1.28. The lowest target is $1.11 and the highest is $1.55. Empower your investment choices with our cutting-edge, data-driven analysis!

KNTPF 股價預測摘要

KNTPF 的頂級分析師評級

根據 7 位分析師對 KNTPF 的股票評級，更新於 Apr 01, 2024

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for KNTPF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: KNTPF is a Buy candidate.

KNTPF stock price ended at $0.35 on 星期三, after rising 6.06%

On the latest trading day Jan 21, 2026, the stock price of KNTPF rose by 6.06%, climbing from $0.35 to $0.35. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.35 and a high of $0.35. Notably, trading volume dropped by 103 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 603 shares were traded, equating to a market value of approximately $164.1M.

KNTPF 技術面訊號

技術面訊號摘要

購買訊號 1

中性訊號 4

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

KNTPF 目前顯示 1 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 59.09%。整體而言，技術指標顯示中期後市趨勢為 Sell。

KNTPF 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為KNTPF生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 KNTPF？



KNTPF 的費波那契回檔水準是多少？



Kintor Pharmaceutical Limited 的 RSI 是多少？



Kintor Pharmaceutical Limited 接下來 12 個月的價格是多少？



Kintor Pharmaceutical Limited 預計會漲到多高？



Kintor Pharmaceutical Limited（KNTPF）價格

KNTPF 股價走勢圖